Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-5194

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-5194). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 5194 3)

Packaging label for Atorvastatin Calcium 40 mg film-coated tablets by NuCare Pharmaceuticals, Inc. The label indicates a quantity of 30 tablets. The tablets are described as oval shaped, white/off-white, and debossed with 'FF3' on one side. The label includes safety warnings and storage instructions at controlled temperature (68-77°F). The NDC number 68071-5194-3 is shown prominently.*

FDA Label Image

Figure (Atorvastatin Calcium Figure 1)

A line graph showing cumulative incidence percentage over years for Atorvastatin versus placebo. The graph plots time in years (0 to 3.5) on the x-axis against cumulative incidence (%) on the y-axis (0 to 4%). Solid line represents Atorvastatin, dashed line represents placebo, indicating lower cumulative incidence with Atorvastatin. Hazard ratio (HR) and p-value are noted on the graph.*

FDA Label Image

Figure (Atorvastatin Calcium Figure 2)

A Kaplan-Meier curve graph showing cumulative hazard percentage over up to five years of follow-up, comparing Atorvastatin and placebo groups. The graph shows time to first primary endpoint with a lower cumulative hazard in the Atorvastatin group. Hazard ratio (HR) 0.63 with confidence intervals (0.48-0.83) and p-value 0.001 are indicated on the graph.*

FDA Label Image

Figure (Atorvastatin Calcium Figure 3)

A line graph comparing the percentage of subjects experiencing a cardiovascular event over time (up to 5 years) between two atorvastatin dosage groups: 10 mg and 80 mg. The graph shows lower event rates for the 80 mg group. The hazard ratio (HR=0.78) with confidence intervals (0.69-0.89) and p-value (0.0002) are displayed on the chart.*

FDA Label Image

Chemical Structure (Atorvastatin Calcium Structure)

Chemical structure of atorvastatin calcium showing its molecular arrangement including aromatic rings, hydroxyl groups, and calcium ion complex with associated water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.